OG

Owen Grogan

Bio-Gene Technology Ltd | Chief Executive Officer, Managing Director
Mr Grogan brings more than 30 years' experience with a track record of delivering growth in the agtech, food and human health sectors. Tim has multi-disciplinary experience in the management of new product development, commercialisation, capital raising and corporate governance. Tim has held several executive roles, in product development and expanding business partnerships. As CEO of SIRA Pty Ltd, Tim led the commercial development of technologies to produce new types of healthier sugar. Prior to this, Tim was the CEO of Dimerix BioScience Pty Ltd, a venture capital-funded medicinal drug discovery and development company, where he managed the development of a novel treatment for diabetic nephropathy and the company completed three pharmaceutical partnering deals within 12 months and expanded its investor base. Tim also has listed company experience, including with pharmaceutical development company, Starpharma (ASX:SPL), where he worked to steer it through the IPO process and establishing several commercial relationships globally.

Company and Roles

Company
Title
Tenure
Since
BGT
Bio-Gene Technology Ltd
  • Chief Executive Officer
  • Managing Director
3yrs, 1mthAug 2023

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
BGT
Bio-Gene Technology Ltd
10/08/260476,916317,392N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
BGT
Bio-Gene Technology Ltd
10/08/26
Issued
200,000$0.025$5,000Placement
BGT
Bio-Gene Technology Ltd
10/08/26
Issued
100,000$0.022$2,200Issue of options
BGT
Bio-Gene Technology Ltd
21/07/25
Issued
217,392$0.018$3,913Issue of options
BGT
Bio-Gene Technology Ltd
21/07/25
Issued
217,392$0.023$5,000Placement
BGT
Bio-Gene Technology Ltd
23/11/23
Issued
59,524$0.084$5,000Placement